Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biliary Tract Adenocarcinoma”

447 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 447 results

Not applicableUnknownNCT02801500
What this trial is testing

Superior Bilioenteric Anastomosis by Magnetic Compressive Technique

Who this might be right for
Hilar CholangiocarcinomaBile Duct InjuryCholedochal Cyst+1 more
First Affiliated Hospital Xi'an Jiaotong University 70
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06901622
What this trial is testing

Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic Cholangiocarcinoma

Who this might be right for
Gallbladder Cancer and Extrahepatic Cholangiocarcinoma
The First Affiliated Hospital of Zhengzhou University 50
Early research (Phase 1)Study completedNCT00654160
What this trial is testing

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Anal CancerCarcinoma of the AppendixColorectal Cancer+9 more
Mayo Clinic 7
Testing effectiveness (Phase 2)Looking for participantsNCT05592626
What this trial is testing

A Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsGenital Neoplasm, FemaleUrogenital Neoplasms+11 more
Marengo Therapeutics, Inc. 366
Early research (Phase 1)Study completedNCT03329950
What this trial is testing

CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

Who this might be right for
MelanomaNon-small Cell Lung CancerBreast Cancer+23 more
Celldex Therapeutics 132
Testing effectiveness (Phase 2)UnknownNCT03943043
What this trial is testing

Gemcitabine + Oxaliplatin +Nab-paclitaxel in Subjects With Advanced Biliary Tract Cancer

Who this might be right for
Cholangiocarcinoma
Istituto Clinico Humanitas 85
Testing effectiveness (Phase 2)Study completedNCT01153750
What this trial is testing

Efficacy of Imatinib and 5-FU/Leucovorin in Patients With Advanced Carcinoma of the Gallbladder and Bile Duct

Who this might be right for
Advanced or Metastatic Cholangiocellular Carcinoma and Bile Duct
University Hospital Dresden 44
Testing effectiveness (Phase 2)Looking for participantsNCT06789848
What this trial is testing

Ligufalimab and Cadonilimab in Advanced Liver Cancers

Who this might be right for
Advanced Hepatocellular CarcinomaRefractory Hepatocellular CarcinomaBiliary Tract Cancer
University of Texas Southwestern Medical Center 64
Testing effectiveness (Phase 2)Study completedNCT02053376
What this trial is testing

Trial of Regorafenib as A Single Agent in Advanced and Metastatic Biliary Tract Carcinoma/Cholangiocarcinoma Patients Who Have Failed First-line Chemotherapy

Who this might be right for
Metastatic Biliary Tract Carcinoma
Nathan Bahary, MD 43
Not applicableEnded earlyNCT00414843
What this trial is testing

Storage of Bile From Routine Procedures to Study Risk Factors

Who this might be right for
Gallbladder CancerCholangiocarcinomaBiliary Tract Cancer
Indiana University 390
Not applicableLooking for participantsNCT05184400
What this trial is testing

Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder Cancer

Who this might be right for
Biliary Tract CancerCholangiocarcinomaGallbladder Cancer
Herlev and Gentofte Hospital 500
Testing effectiveness (Phase 2)Study completedNCT03830606
What this trial is testing

The Efficacy and Safety of Nab-paclitaxel Plus S-1 in First-line Treatment of Advanced Biliary Tract Adenocarcinoma

Who this might be right for
Biliary Tract Cancer
Aiping Zhou 54
Testing effectiveness (Phase 2)Study completedNCT00948935
What this trial is testing

Study of Gemcitabine, Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract Adenocarcinoma

Who this might be right for
Biliary CancerCholangiocarcinoma
Abramson Cancer Center at Penn Medicine 35
Testing effectiveness (Phase 2)Ended earlyNCT00085410
What this trial is testing

Bortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder

Who this might be right for
Adenocarcinoma of the Extrahepatic Bile DuctAdenocarcinoma of the GallbladderAdvanced Adult Primary Liver Cancer+7 more
National Cancer Institute (NCI) 20
Not applicableNo Longer AvailableNCT04087876
What this trial is testing

Expanded Access Use of Derazantinib for Advanced Intrahepatic Cholangiocarcinoma (iCCA) With FGFR Genomic Alterations

Who this might be right for
Intrahepatic Cholangiocarcinoma
Basilea Pharmaceutica
Testing effectiveness (Phase 2)Study completedNCT00009893
What this trial is testing

Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
Alliance for Clinical Trials in Oncology 42
Early research (Phase 1)Ended earlyNCT02714374
What this trial is testing

GL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ Cancers

Who this might be right for
Solid Organ Cancers
Andrew Lowy 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT04430738
What this trial is testing

Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers

Who this might be right for
Colorectal CarcinomaGastric AdenocarcinomaGEJ Adenocarcinoma+3 more
Seagen, a wholly owned subsidiary of Pfizer 40
Not applicableActive Not RecruitingNCT03695952
What this trial is testing

A Prospective Cohort Study of Patients with Hepatobiliary Cancer Treated with Immune Checkpoint Inhibitors

Who this might be right for
Hepatocellular CarcinomaBiliary Tract Cancer
Asan Medical Center 100
Not applicableStudy completedNCT01673269
What this trial is testing

Prospective Study of the Risk of Bacteremia in Directed Cholangioscopic Examination of the CBD

Who this might be right for
CholedocholithiasisCholangiocarcinomaBenign Stricture of Common Bile Duct
Texas Tech University Health Sciences Center, El Paso 60
Next Page